DIRECTIONAL TRANSPORT OF MULV GLYCOPROTEINS
DIRECTIONAL TRANSPORT OF MULV GLYCOPROTEINS
批准号:
3164991
负责人:
RICHARD W COMPANS
金额:
$11.0万
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-06-01 至 1990-06-30
关键词:
Retroviridae Retroviridae disease basolateral membrane gene expression genetic manipulation genetic recombination genetic translation glycoproteins immunofluorescence technique membrane proteins messenger RNA molecular oncology murine leukemia virus neoplasm /cancer genetics nucleocapsid protein biosynthesis protein signal sequence protein structure temperature sensitive mutant tissue /cell culture transport proteins viral leukemogenesis virus envelope virus genetics virus infection mechanism virus protein virus replication viruslike particle
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our objective is to define the molecular basis by which membrane
glycoproteins are directionally transported to specific cellular
locations. These investigations will be carried out using viral
glycoproteins which are transported to different plasma membrane domains on
surfaces of polarized epithelial cells. To identify sorting signals
responsible for the directional transport of glycoproteins, we will analyze
the effects of specific modifications and sequence substitutions on
determining the cellular location of the resulting molecules. These
studies will be carried out with viral glycoproteins which exhibit distinct
orientations and transmembrane topology: the gp70/p15E glycoprotein of
murine leukemia viruses, a bitopic membrane glycoprotein with a cleaved
signal sequence that is anchored by hydrophobic residues near the
C-terminus of the molecule, and the gPr-gag glycoprotein which is likely to
be anchored to membranes in the opposite orientation. In order to
characterize the intracellular transport pathway of MuLV glycoproteins, we
will use specific antisera to identify transport vesicles involved in
movement of glycoproteins from the Golgi complex to the plasma membrane.
We will determine whether the two MuLV-encoded glycoproteins gp70/p15E and
gPr-gag are present in the same population of transport vesicles and
whether they are associated with one another on the plasma membrane. To
further define the viral components which are involved in determining the
maturation site of retroviruses in epithelial cells, we will investigate
the site of virus assembly and release in cells which produce viral cores
in the absence of viral glycoproteins, and determine the effects of
supplementing these cells with viral glycoproteins directed to either the
apical or basolateral membranes. In addition to providing a better
understanding of basic cellular processes, the proposed studies should
contribute to our knowledge concerning the pathogenesis of viral infections
by elucidating the mechanisms by which viral components are targeted to
particular locations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Skin Vaccination Against Influenza in the Young And Aged
-
批准号:9210049
-
项目类别:
-
资助金额:$67.49万
-
财政年份:2015
-
负责人:RICHARD W COMPANS
-
依托单位:
Skin Vaccination Against Influenza in the Young And Aged
-
批准号:8886505
-
项目类别:
-
资助金额:$70.29万
-
财政年份:2015
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8257884
-
项目类别:
-
资助金额:$99.15万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8650780
-
项目类别:
-
资助金额:$102.71万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8463750
-
项目类别:
-
资助金额:$94.84万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC)
-
批准号:8357468
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8076663
-
项目类别:
-
资助金额:$96.61万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8837557
-
项目类别:
-
资助金额:$120.24万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
VLP VACCINES FOR HIV PREVENTION
-
批准号:8357486
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:8278665
-
项目类别:
-
资助金额:$49.29万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC)
-
批准号:8172422
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:8471051
-
项目类别:
-
资助金额:$46.33万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:8075656
-
项目类别:
-
资助金额:$49.22万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
REGULATION OF MEMBRANE FUSION
-
批准号:8172444
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:7988855
-
项目类别:
-
资助金额:$49.72万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
REGULATION OF MEMBRANE FUSION
-
批准号:7958272
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2009
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC
-
批准号:7958248
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2009
-
负责人:RICHARD W COMPANS
-
依托单位:
Novel VLP vaccines for pandemic influenza virus
-
批准号:7914758
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2009
-
负责人:RICHARD W COMPANS
-
依托单位:
Novel Vaccine Strategies Against Ebola Virus
-
批准号:7372039
-
项目类别:
-
资助金额:$38.35万
-
财政年份:2008
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC
-
批准号:7715853
-
项目类别:
-
资助金额:$3.56万
-
财政年份:2008
-
负责人:RICHARD W COMPANS
-
依托单位: